Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity

NCT01382576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2012-03-12

No results posted yet for this study

Summary

In the present study, serum chitotriosidase activity and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS).

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Gulhane School of Medicine

    lead OTHER

Principal Investigators

  • Aydogan Aydogdu, MD · No organizational affiliation

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382576 on ClinicalTrials.gov